Search
Descriptor in English: Vildagliptin
Descriptor in Spanish: Vildagliptina
Descriptor in Portuguese: Vildagliptina
Descriptor in French: Vildagliptine
Entry term(s): (2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
Galvus
NVP LAF237
NVP-LAF237
Tree number(s): D02.626.943
D03.383.773.953
Scope note: A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
History Note: 2019 (2005)
DeCS UI: 57704
Descriptor UI: D000077597
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Vildagliptin - Preferred
Concept UI M0486919
Scope note A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.
Preferred term Vildagliptin
Entry term(s) (2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
NVP-LAF237 - Narrower
Concept UI M0486922
Preferred term NVP-LAF237
Entry term(s) NVP LAF237
Galvus - Narrower
Concept UI M0498839
Preferred term Galvus



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey